According to Vericel 's latest financial reports and stock price the company's current Operating Margin is -4.85%. At the end of 2021 the company had an Operating Margin of -4.85%.
Year | Operating Margin | Change |
---|---|---|
2021 | -4.85% | -298.04% |
2020 | 2.45% | -129.89% |
2019 | -8.20% | -8.43% |
2018 | -8.96% | -66.88% |
2017 | -27.04% | -24.84% |
2016 | -35.98% | 12.66% |
2015 | -31.93% | -53.84% |
2014 | -69.18% | -99.92% |
2013 | -82,221.05% | -41.42% |
2012 | -140,352.38% | -13% |
2011 | -161,333.33% | 706.49% |
2010 | -20,004.49% | 125.17% |
2009 | -8,884.07% | 118.55% |
2008 | -4,064.94% | 43.02% |
2007 | -2,842.19% | 38.32% |
2006 | -2,054.81% | 50.42% |
2005 | -1,366.01% | 66.89% |
2004 | -818.51% | -28.88% |
2003 | -1,150.83% | 21.88% |
2002 | -944.24% | 29.03% |
2001 | -731.81% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Royalty Pharma RPRX | 27.89% | -675.05% | ๐ฌ๐ง UK |
Neogen NEOG | -2.68% | -44.74% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.